Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.

Gq protein HTR2B LSD functional selectivity psychedelic signaling transduction structural biology β-arrestin-1

Journal

Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320

Informations de publication

Date de publication:
05 Oct 2022
Historique:
received: 24 03 2022
revised: 13 07 2022
accepted: 12 08 2022
pubmed: 11 9 2022
medline: 12 10 2022
entrez: 10 9 2022
Statut: ppublish

Résumé

Serotonin (5-hydroxytryptamine [5-HT]) 5-HT2-family receptors represent essential targets for lysergic acid diethylamide (LSD) and all other psychedelic drugs. Although the primary psychedelic drug effects are mediated by the 5-HT

Identifiants

pubmed: 36087581
pii: S0896-6273(22)00752-8
doi: 10.1016/j.neuron.2022.08.006
pmc: PMC9583076
mid: NIHMS1835617
pii:
doi:

Substances chimiques

Hallucinogens 0
Receptors, Serotonin 0
beta-Arrestins 0
Serotonin 333DO1RDJY
Lysergic Acid Diethylamide 8NA5SWF92O

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3154-3167.e7

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM127359
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112205
Pays : United States
Organisme : NIDA NIH HHS
ID : R37 DA045657
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The Krogan Laboratory has received research support from Vir Biotechnology, F. Hoffmann-La Roche, and Rezo Therapeutics. N.J.K. has financially compensated consulting agreements with the Icahn School of Medicine at Mount Sinai, New York; Maze Therapeutics; Interline Therapeutics; Rezo Therapeutics; GEn1E Life Sciences, Inc.; and Twist Bioscience Corp. N.J.K. is on the Board of Directors of Rezo Therapeutics and is a shareholder in Tenaya Therapeutics, Maze Therapeutics, Rezo Therapeutics, and Interline Therapeutics. G.S. is co-founder and consultant for Deep Apple Therapeutics.

Références

J Psychedelic Drugs. 1979 Jan-Jun;11(1-2):53-60
pubmed: 392118
Nat Commun. 2014 Sep 10;5:4801
pubmed: 25205354
Ther Adv Psychopharmacol. 2020 Aug 27;10:2045125320950567
pubmed: 32922736
Cell. 2015 May 21;161(5):1101-1111
pubmed: 25981665
Nat Struct Mol Biol. 2018 Sep;25(9):787-796
pubmed: 30127358
Cell. 2020 Dec 23;183(7):1813-1825.e18
pubmed: 33296703
CNS Neurosci Ther. 2008 Winter;14(4):295-314
pubmed: 19040555
Sci Signal. 2011 Aug 9;4(185):ra51
pubmed: 21868357
Mol Pharmacol. 2017 Sep;92(3):201-210
pubmed: 28246190
Sci Adv. 2020 Sep 11;6(37):
pubmed: 32917711
Pharmacol Rev. 2016 Apr;68(2):264-355
pubmed: 26841800
Cell. 2013 Jan 31;152(3):532-42
pubmed: 23374348
Science. 2020 Feb 21;367(6480):888-892
pubmed: 32079768
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Cell. 2017 Jan 26;168(3):377-389.e12
pubmed: 28129538
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Bioinformatics. 2006 Mar 1;22(5):623-5
pubmed: 16397007
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6733-8
pubmed: 22493271
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
J Chem Theory Comput. 2015 Apr 14;11(4):1864-74
pubmed: 26574392
Science. 2012 Mar 2;335(6072):1106-10
pubmed: 22267580
Cell. 2019 Jan 24;176(3):448-458.e12
pubmed: 30639101
N Engl J Med. 2007 Jan 4;356(1):6-9
pubmed: 17202450
Nature. 2018 May;557(7705):318-319
pubmed: 29752449
Science. 1990 Jun 22;248(4962):1547-50
pubmed: 2163110
Nature. 2018 May;557(7705):381-386
pubmed: 29720660
Clin Pharmacol Ther. 1965 Mar-Apr;6:183-255
pubmed: 14288188
J Pharmacol Exp Ther. 2011 Feb;336(2):296-302
pubmed: 21030484
Nature. 2015 Aug 13;524(7564):173-179
pubmed: 26147082
J Chem Theory Comput. 2013 Sep 10;9(9):3878-88
pubmed: 26592383
Nature. 2013 May 2;497(7447):137-41
pubmed: 23604254
Nat Rev Drug Discov. 2022 Jun;21(6):463-473
pubmed: 35301459
FEBS Lett. 1984 Oct 29;176(2):473-8
pubmed: 6436059
Commun Biol. 2021 Jul 15;4(1):874
pubmed: 34267316
J Biol Chem. 1995 Jan 13;270(2):503-6
pubmed: 7822269
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
Nat Struct Mol Biol. 2015 May;22(5):362-9
pubmed: 25895059
Nucleic Acids Res. 2018 Jan 4;46(D1):D440-D446
pubmed: 29155946
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
J Neurochem. 1999 May;72(5):2206-14
pubmed: 10217304
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Nat Commun. 2015 Sep 08;6:8202
pubmed: 26347956
Biochemistry. 2014 Nov 25;53(46):7283-96
pubmed: 25347607
PLoS One. 2010 Nov 30;5(11):e14135
pubmed: 21152433
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nature. 2020 Jul;583(7818):862-866
pubmed: 32555462
Cell. 2016 Aug 11;166(4):907-919
pubmed: 27499021
Science. 2013 May 3;340(6132):615-9
pubmed: 23519215
Pharmacol Ther. 2006 Jun;110(3):465-502
pubmed: 16460808
J Biol Chem. 2000 Feb 4;275(5):3121-7
pubmed: 10652295
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11934-9
pubmed: 12192085
J Pharmacol Exp Ther. 2007 Jan;320(1):1-13
pubmed: 16803859
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Nature. 2020 Mar;579(7798):303-308
pubmed: 31945771
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Nat Commun. 2019 Mar 19;10(1):1261
pubmed: 30890705
Cell. 2017 Jul 27;170(3):457-469.e13
pubmed: 28753425
Nature. 2015 Jul 30;523(7562):561-7
pubmed: 26200343
Nat Commun. 2021 Apr 22;12(1):2396
pubmed: 33888704
Science. 2020 Feb 21;367(6480):881-887
pubmed: 32079767
J Psychopharmacol. 2019 Sep;33(9):1039-1057
pubmed: 31303095
Cell Res. 2019 Dec;29(12):971-983
pubmed: 31776446
Cell. 2020 Sep 17;182(6):1574-1588.e19
pubmed: 32946782
Nature. 2020 Mar;579(7798):297-302
pubmed: 31945772
Proteins. 1996 Apr;24(4):433-8
pubmed: 9162944
J Phys Chem B. 2010 Jun 17;114(23):7830-43
pubmed: 20496934
Trends Pharmacol Sci. 2014 Jul;35(7):308-16
pubmed: 24878326
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8223-8228
pubmed: 28716900

Auteurs

Can Cao (C)

Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599-7365, USA.

Ximena Barros-Álvarez (X)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.

Shicheng Zhang (S)

Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599-7365, USA.

Kuglae Kim (K)

Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599-7365, USA.

Marc A Dämgen (MA)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA; Department of Computer Science, Stanford University, Stanford, CA 94305, USA; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA 94305, USA.

Ouliana Panova (O)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.

Carl-Mikael Suomivuori (CM)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA; Department of Computer Science, Stanford University, Stanford, CA 94305, USA; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA 94305, USA.

Jonathan F Fay (JF)

Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 7599-7365, USA.

Xiaofang Zhong (X)

Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA; J. David Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.

Brian E Krumm (BE)

Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599-7365, USA.

Ryan H Gumpper (RH)

Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599-7365, USA.

Alpay B Seven (AB)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.

Michael J Robertson (MJ)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.

Nevan J Krogan (NJ)

Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA; J. David Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.

Ruth Hüttenhain (R)

Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA; J. David Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.

David E Nichols (DE)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599-7365, USA.

Ron O Dror (RO)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA; Department of Computer Science, Stanford University, Stanford, CA 94305, USA; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA 94305, USA. Electronic address: ron.dror@stanford.edu.

Georgios Skiniotis (G)

Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: yiorgo@stanford.edu.

Bryan L Roth (BL)

Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599-7365, USA; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599-7365, USA. Electronic address: bryan_roth@med.unc.edu.

Articles similaires

Cerebrospinal Fluid Animals Liver Glymphatic System Spinal Cord
Animals Sumatriptan Tryptamines Rats Male

Fluorescent non-canonical amino acid provides insight into the human serotonin transporter.

Andreas Nygaard, Linda G Zachariassen, Kathrine S Larsen et al.
1.00
Serotonin Plasma Membrane Transport Proteins Humans Serotonin Amino Acids Sodium
Animals Dendritic Cells Serotonin Mice Signal Transduction

Classifications MeSH